View Older Stories

Jul 10, 2025 04:10AM BTIG Downgrades Verona Pharma (VRNA) to Neutral

Jul 9, 2025 04:28PM Wells Fargo Downgrades Verona Pharma (VRNA) to Equal Weight

Jul 9, 2025 12:16PM TD Cowen Downgrades Verona Pharma (VRNA) to Hold Following Merck Takeover

Jul 9, 2025 09:46AM Jefferies Downgrades Verona Pharma (VRNA) to Hold

Jul 9, 2025 08:28AM Stifel: 'MRK Acquisition of VRNA Should Broaden Opportunity for Ohtuvayre – A Core LGND Growth Driver'

Jul 9, 2025 06:30AM Merck to acquire Verona Pharma for $10 billion to add COPD treatment

Jul 9, 2025 05:32AM Verona Pharma plc (VRNA) call put ratio 1 call to 3.7 puts into share price up before the bell

Jul 7, 2025 09:44AM Piper Sandler on Verona Pharma (VRNA): 'OHTUVAYRE COPD Launch a Blockbuster Opportunity'

Jun 30, 2025 04:33PM Wolfe Research Starts Verona Pharma (VRNA) at Outperform

Jun 23, 2025 08:57AM Verona Pharma (VRNA) PT Raised to $160 from $76 as Piper Sandler 'Remains Bullish'

Jun 16, 2025 10:33AM Increasing unusual put option volume: VRNA FIVN WEN VTLE CPB CALM SATS APPS SRPT KMX SLG TSSI TMC ALT EH ESTC AEO KULR IOVA

Jun 11, 2025 06:45AM Cantor Fitzgerald Reiterates Overweight Rating on Verona Pharma (VRNA)

Jun 11, 2025 05:34AM Verona Pharma (VRNA) PT Raised to $110 at Jefferies

Jun 5, 2025 07:25AM Piper Sandler on Verona Pharma (VRNA): 'We Remain Highly Bullish and See Substantial Upside'

Jun 2, 2025 06:44AM Verona Pharma (VRNA) PT Raised to $90 at H.C. Wainwright

May 30, 2025 08:44AM Jefferies Bangs Table on Verona Pharma (VRNA), Top Pick, 'We think Ohtuvayre (novel PDE3/4) is tracking to become an attractive $2.5B+ add-on therapy'

May 22, 2025 08:26AM Truist on Verona Pharma (VRNA): 'We Continue to See a Potential Blockbuster in Ohtuvayre'

May 8, 2025 02:25PM Verona Pharma plc (VRNA) spreader focusing on May 55 and June 60 puts

Apr 29, 2025 06:04AM Verona Pharma plc (VRNA) Tops Q1 EPS by 5c

Apr 28, 2025 05:31AM TD Cowen Starts Verona Pharma (VRNA) at Buy

Apr 21, 2025 06:32AM Cantor Fitzgerald Starts Verona Pharma (VRNA) at Overweight

Apr 11, 2025 09:44AM Piper Sandler: 'What Biotech Names to Own in Market Volatility'

Mar 28, 2025 08:01AM Xeris Pharmaceuticals (XERS) Announces Board Changes

Mar 28, 2025 07:00AM Verona Pharma plc (VRNA) Announces Amended Strategic Financing with Oaktree and OMERS

Mar 11, 2025 10:21AM Increasing unusual put option volume: IEF TER HSBC VRNA ASAN CNC FL URNM MDY BDX

Feb 28, 2025 08:40AM Verona Pharma (VRNA) PT Raised to $76 at Truist Securities

Feb 28, 2025 07:04AM Verona Pharma (VRNA) PT Raised to $75 at H.C. Wainwright

Feb 27, 2025 06:19AM Verona Pharma plc (VRNA) Tops Q4 EPS by 2c

Feb 21, 2025 06:09AM Verona Pharma (VRNA) PT Raised to $80 at Jefferies

Feb 12, 2025 06:37AM Verona Pharma (VRNA) PT Raised to $72 at Canaccord Genuity

Jan 21, 2025 06:37AM Verona Pharma (VRNA) PT Raised to $60 at H.C. Wainwright

Jan 10, 2025 09:05AM Roth/MKM Starts Verona Pharma (VRNA) at Buy

Jan 8, 2025 10:03AM Verona Pharma (VRNA) PT Raised to $57 at Truist Securities as Ohtuvayre Sales Exceed Expectations

Jan 7, 2025 04:35PM Verona Pharma (VRNA) PT Raised to $77 at BTIG

Jan 7, 2025 06:02AM Verona Pharma plc (VRNA) Reports Strong Ohtuvayre Launch; Offers Guidance

Dec 10, 2024 09:15AM Ligand Pharma (LGND) Introduces 2025 Guidance

Nov 5, 2024 06:42AM Verona Pharma (VRNA) PT Raised to $42 at H.C. Wainwright

Nov 4, 2024 02:20AM Verona Pharma plc (VRNA) Reports In-Line Q3 EPS

Oct 3, 2024 07:12AM Piper Sandler Reiterates Overweight Rating on Verona Pharma (VRNA)

Oct 3, 2024 06:04AM Wells Fargo Starts Verona Pharma (VRNA) at Overweight

Oct 1, 2024 06:57AM H.C. Wainwright Reiterates Buy Rating on Verona Pharma (VRNA)

Sep 18, 2024 06:39AM H.C. Wainwright Reiterates Buy Rating on Verona Pharma (VRNA)

Sep 12, 2024 07:49AM H.C. Wainwright Reiterates Buy Rating on Verona Pharma (VRNA)

Aug 22, 2024 06:59AM Piper Sandler Reiterates Overweight Rating on Verona Pharma (VRNA)

Aug 14, 2024 08:21AM Piper Sandler Reiterates Overweight Rating on Verona Pharma (VRNA)

Aug 8, 2024 03:40AM Verona Pharma plc (VRNA) Misses Q2 EPS by 6c

Jul 22, 2024 06:30AM Verona Pharma (VRNA) PT Raised to $37 at Canaccord Genuity

Jul 1, 2024 06:39AM H.C. Wainwright Reiterates Buy Rating on Verona Pharma (VRNA)

Jun 27, 2024 01:57PM Verona Pharma (VRNA) PT Raised to $38 at Truist Securities

Jun 27, 2024 09:26AM Piper Sandler Reiterates Overweight Rating on Verona Pharma (VRNA)

View Older Stories